 - Participant received immunomodulatory or immunosuppressive therapy including but not limited to cyclophosphamide, cyclosporin, methotrexate, azathioprine, linomide, mitoxantrone, teriflunomide, natalizumab, laquinimod, Campath within the 12 months prior to SD1. 